accountbe part of the next wave of heart drugs. The findings may jeopardize other medicines in development, including Merck & Co.���s Cordaptive and anacetrapib, and Roche Holding AG���s dalcetrapib. ���The lack of effect on cardiovascular events is unexpected...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Cholesterol Combination Fails to Protect Heart in Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account